Yes-activated protein promotes primary resistance of BRAF V600E mutant metastatic colorectal cancer cells to mitogen-activated protein kinase pathway inhibitors

Meng Su(Hunan University of Traditional Chinese Medicine), Jingdong Zhang(Liaoning Cancer Hospital & Institute)
Journal of Gastrointestinal Oncology
June 1, 2021
Cited by 11


Related Papers